Modulation by chlorophyllin of benzo(a)pyrene (BP)-dependent CYP1 induction and DNA adduct formation in normal human mammary cells (NHMECs) and MCF-7 cells.
Authors
John K; Divi RL; Keshava C; Whipkey DL; Poirier ML; Orozco C; Shockley M; Weston A; NathnJ
Malignantly transformed cell lines are frequently used as surrogate in vitro models for normal cell strains because they are easy to maintain. We compared the response of NHMEC strains to BP exposure with that of the malignant human mammary cell line MCF-7 in the presence and absence of chlorophyllin, a water soluble metaloporphyrin known to have anticarcinogenic properties. Cells were exposed to BP (4uM, 24h) in 4 treatment scenarios: T1-BP alone, T2-BP together with chlorophyllin, T3-BP after 24h pretreatment with chlorophyllin, T4-BP after 24h pretreatment with chlorophyllin and together with chlorophyllin. CYP1 induction was measured by reverse-transcription, real-time polymerase chain reaction (RT-PCR). Comparison of 20 NHMEC strains revealed inter-individual variation in both CYP1 induction (3-96 fold) and CYP1B1 induction (2-43 fold). BP-DNA adducts measured by (+/-)r7, t8-dihydroxy-c9,t10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene-DNA chemiluminescence immunoassay, also showed inter-individual variation of 3-58 BP-DNA adducts/10(8) nucleotides in NHMECs exposed only to BP. Chlorophyllin treatment T4, the most effective in reducing BP dependent CYP induction and BP-DNA adducts, reduced CYP1A1 induction by 5-88% in 19/20 cell strains, and CYP1B1 induction by 10-83% in 18/20 cell strains. Similarly, DNA adduct levels were reduced by 25-87% in all the 20 cell strains exposed to treatment T4. In MCF-7 cells basal CYP1A1 and CYP1B1 RNA levels were comparable to NHMEC strains when measured by RT-PCR normalized to GAPDH. In MCF-7 cells exposed to BP, CYP1A1 was induced 114 fold and CYP1B1 by 5 fold. Formation of BP-DNA adducts in MCF-7 cells was 10 fold higher than in the highest NHMEC strain (609/10(8) nucleotides). Also, CYP induction and DNA adducts were not altered by chlorophyllin exposure. Therefore, compared to most NHMEC strains, MCF-7 cells have a highly inducible CYP1A1 and a high capacity for BP-DNA adduct formation, suggesting that these cell strains are an inappropriate surrogate model of human mammary carcinogenesis. The most important findings of this study are that chlorophyllin reduces CYP1A1 and CYP1B1 induction and BP-DNA adduct formation, in response to BP exposure. The data suggest that chlorophyllin has anticarcinogenic activity in normal human mammary tissue.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.